| Factor Information | |
|---|---|
| Data ID | 1891 |
| Factor | Procedure-type categories 3 |
| Description | In multivariate analysis, procedure-type category 3 had an odds ratio of 1.7 (95% CI: 1.2–2.3, P = .003) and category 4 one of 2.3 (95% CI: 1.4–3.6, P = .001) when compared with category 2. In ultivariate analysis, procedure-type category 3 had an odds ratio of 3.1 (95% CI: 1.6–6.0, P = .001) and category 4 had one of 6.8 (95% CI 3.2–14.4, P < .001) when compared with category 2. |
| Biomarker | NA |
| Classification | A9 (clinical factor - risk category) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | with transcatheter interventions in congenital heart disease and examine predictors for adverse events. |
| p Value | 0.003 |
| OR | 1.7 |
| Conclusion | We found an increase in number of procedures over time and a decrease in frequency of adverse events. Higher procedure-type risk categories were associated with increased risk of adverse events. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 562 |
| CHD Type | isolated CHD |
| CHD Subtype | PDA/ASD/PV/PAS/TGA/CoA/PFO/AVS/PA/TOF/DORV/UVH/VSD/other |
| Reference | |
|---|---|
| PMID | 25196278 |
| Year | 2015 |
| Title | Adverse events in transcatheter interventions for congenital heart disease: a population-based long-term study |
| Sample | ||
|---|---|---|
| Population | All | |
| Source | N/A | |
| Region | Aarhus, Denmark | |
| Method | N/A | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | Transcatheter Interventions | |
| Group | Procedure-type categories 3(Treatment) | Procedure-type categories 2(Control) |
| Number | N/A | 296 |
| Age | Age, median (IQR): 5.3 (1.1–22.3)(patients with 4 procedures) | Age, median (IQR): 5.3 (1.1–22.3)(patients with 2 procedures) |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | N/A | N/A |
